Indian Company Master Data Made Simple
Aarti Drugs Limited
Aarti Drugs Limited, formed in 1984, has been in existence for 4. The company’s Corporate Identification Number is L37060MH1984PLC055433; registration no. 55433. The firm is categorized as company limited by shares. The company’s authorized capital value is ₹120.00 crore. Paid-up capital for the company equals ₹91.27 crore.
Its core business comprises recycling. Aarti Drugs Limited is officially registered in Mumbai. Its official registered office is situated at Plot No 198 Midc Tarapurtal.palghar Village Pamtermbhi, Dist Thane, Maharashtra, India, 401506. The entity is active and conducting operations. The firm is identified under PAN AAACA4410D. Aarti Drugs Limited is identified globally under LEI 3358008CHU25M2YZMB20. For correspondence, the registered email address is investorrelations@aartidrugs.com. Key executives of the company are: Prakash Moreshwar Patil (CEO) and Adhish Prakash Patil (CFO).
Company Overview
- CIN
- Date of Incorporation
- 27/09/1984
- Company Status
- Active
- RoC
- Mumbai
- Registration Number
- Balance sheet date
- 31/03/2024
- Company Category
- Company limited by shares
- Company Sub Category
- Non-government company
- Listed in Stock Exchange
- Yes
- Class of Company
- Public Limited Company
- LEI Number
- LEI Status
- Issued
- Authorized Capital
- ₹1,20,00,00,000.00
- Paid up Capital
- ₹91,27,00,000.00
- Activity
- RECYCLING
- investorrelations@aartidrugs.com
- PAN
ISIN Numbers
| ISIN | Security | Interest Rate | Maturity Date | FISN | CFI |
|---|---|---|---|---|---|
| INE767A01016 | AARTI DRUGS LIMITED EQ | - | 12/10/2026 | AARTI DRUGS/SH VTG | ESVUFN |
| IN8767A01015 | AARTI DRUGS LIMITED EQ LISTING/TRADING APPROVAL AWAITED | - | 12/10/2026 | AARTI DRUGS/SH VTG | ESVUFN |
Balance Sheet
| Metric | 31/03/2026 | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 |
|---|---|---|---|---|---|
| Net PPE | ₹1,21,072.88L | ₹1,14,990.59L | ₹1,05,394.02L | ₹88,591.58L | ₹0.00L |
| Net Debt | ₹56,755.72L | ₹60,766.54L | ₹55,567.37L | ₹59,901.58L | ₹0.00L |
| Gross PPE | ₹1,89,884.39L | ₹1,77,667.53L | ₹1,62,854.11L | ₹1,41,187.23L | ₹0.00L |
| Inventory | ₹49,078.08L | ₹47,292.83L | ₹48,589.23L | ₹51,629.10L | ₹0.00L |
| Total Debt | ₹57,663.25L | ₹61,507.07L | ₹56,428.00L | ₹60,891.45L | ₹0.00L |
| Common Stock | ₹9,127.00L | ₹9,127.00L | ₹9,193.50L | ₹9,260.00L | ₹0.00L |
| Current Debt | ₹31,795.63L | ₹32,824.25L | ₹28,708.72L | ₹40,184.19L | ₹0.00L |
| Share Issued | ₹912.70L | ₹912.70L | ₹919.35L | ₹926.00L | ₹0.00L |
| Total Assets | ₹2,81,526.42L | ₹2,57,467.82L | ₹2,43,235.80L | ₹2,42,139.82L | ₹0.00L |
| Capital Stock | ₹9,127.00L | ₹9,127.00L | ₹9,193.50L | ₹9,260.00L | ₹0.00L |
| Long Term Debt | ₹25,686.98L | ₹28,400.00L | ₹27,532.92L | ₹20,467.73L | ₹0.00L |
| Current Assets | ₹1,46,777.36L | ₹1,33,835.50L | ₹1,32,071.99L | ₹1,49,178.82L | ₹0.00L |
| Prepaid Assets | ₹11,149.89L | ₹8,366.09L | ₹11,310.51L | ₹9,512.66L | ₹0.00L |
| Working Capital | ₹54,551.77L | ₹50,138.82L | ₹52,517.72L | ₹54,231.11L | ₹0.00L |
| Invested Capital | ₹2,12,368.71L | ₹1,98,124.11L | ₹1,84,396.49L | ₹1,79,895.39L | ₹0.00L |
| Other Properties | ₹169.75L | ₹270.28L | ₹175.05L | ₹218.64L | ₹0.00L |
| Retained Earnings | ₹1,40,000.72L | ₹1,24,026.59L | ₹1,15,524.84L | ₹1,02,053.49L | ₹0.00L |
| Common Stock Equity | ₹1,54,886.10L | ₹1,36,899.85L | ₹1,28,154.85L | ₹1,19,243.47L | ₹0.00L |
| Net Tangible Assets | ₹1,44,009.37L | ₹1,30,581.07L | ₹1,24,472.95L | ₹1,16,810.56L | ₹0.00L |
| Tangible Book Value | ₹1,44,009.37L | ₹1,30,581.07L | ₹1,24,472.95L | ₹1,16,810.56L | ₹0.00L |
| Current Liabilities | ₹92,225.59L | ₹83,696.68L | ₹79,554.27L | ₹94,947.71L | ₹0.00L |
| Long Term Provisions | ₹455.00L | ₹433.00L | ₹274.00L | ₹726.77L | ₹0.00L |
| Stockholders Equity | ₹1,54,886.10L | ₹1,36,899.85L | ₹1,28,154.85L | ₹1,19,243.47L | ₹0.00L |
| Other Equity Interest | ₹1,45,759.00L | -₹0.01L | ₹1,18,962.00L | ₹1,09,983.00L | ₹0.00L |
| Total Capitalization | ₹1,80,573.08L | ₹1,65,299.86L | ₹1,55,687.77L | ₹1,39,711.20L | ₹0.00L |
| Ordinary Shares Number | ₹912.70L | ₹912.70L | ₹919.35L | ₹926.00L | ₹0.00L |
| Other Intangible Assets | ₹10,876.73L | ₹6,318.78L | ₹3,681.90L | ₹2,432.91L | ₹0.00L |
| Other Non Current Assets | ₹1,997.00L | ₹1,762.00L | ₹1,970.00L | ₹2,367.00L | ₹0.00L |
| Total Non Current Assets | ₹1,34,749.06L | ₹1,23,632.32L | ₹1,11,163.27L | ₹92,960.48L | ₹0.00L |
| Cash And Cash Equivalents | ₹726.89L | ₹457.72L | ₹674.27L | ₹750.34L | ₹0.00L |
| Construction In Progress | ₹14,075.70L | ₹29,094.83L | ₹24,403.10L | ₹21,048.30L | ₹0.00L |
| Accumulated Depreciation | -₹68,811.51L | ₹0.00L | -₹57,460.09L | -₹52,595.65L | -₹47,906.36L |
| Additional Paid In Capital | ₹494.98L | ₹494.98L | ₹428.48L | ₹361.98L | ₹0.00L |
| Other Short Term Investments | ₹88.83L | ₹241.41L | ₹218.58L | ₹87.95L | ₹0.00L |
| Other Non Current Liabilities | -₹0.46L | -₹0.43L | -₹0.01L | -₹0.33L | ₹0.00L |
| Machinery Furniture Equipment | ₹1,36,544.02L | ₹1,14,633.49L | ₹1,06,327.95L | ₹91,219.16L | ₹0.00L |
| Goodwill And Other Intangible Assets | ₹10,876.73L | ₹6,318.78L | ₹3,681.90L | ₹2,432.91L | ₹0.00L |
| Total Equity Gross Minority Interest | ₹1,54,922.56L | ₹1,36,934.28L | ₹1,28,195.43L | ₹1,19,266.80L | ₹0.00L |
| Total Liabilities Net Minority Interest | ₹1,26,603.86L | ₹1,20,533.54L | ₹1,15,040.37L | ₹1,22,873.02L | ₹0.00L |
| Current Debt And Capital Lease Obligation | ₹31,890.28L | ₹32,942.00L | ₹28,803.68L | ₹40,383.41L | ₹0.00L |
| Long Term Debt And Capital Lease Obligation | ₹25,772.97L | ₹28,565.07L | ₹27,624.32L | ₹20,508.04L | ₹0.00L |
| Cash Cash Equivalents And Short Term Investments | ₹815.72L | ₹699.13L | ₹892.85L | ₹838.29L | ₹0.00L |
| Total Non Current Liabilities Net Minority Interest | ₹34,378.27L | ₹36,836.86L | ₹35,486.10L | ₹27,925.31L | ₹0.00L |
Cash Flow
| Metric | 31/03/2026 | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 |
|---|---|---|---|---|---|
| Net Income | ₹19,492.00L | ₹16,816.00L | ₹17,142.00L | ₹16,631.00L | ₹0.00L |
| Free Cash Flow | ₹8,021.71L | ₹6,742.24L | ₹13,258.87L | -₹3,149.66L | ₹0.00L |
| Changes In Cash | ₹268.84L | -₹216.55L | -₹76.07L | -₹1,410.86L | ₹0.00L |
| End Cash Position | ₹726.56L | ₹457.72L | ₹674.27L | ₹750.34L | ₹0.00L |
| Financing Cash Flow | -₹7,744.35L | -₹8,211.85L | -₹13,603.31L | ₹1,654.22L | ₹0.00L |
| Investing Cash Flow | -₹17,340.66L | -₹16,463.08L | -₹22,365.08L | -₹16,397.20L | ₹0.00L |
| Operating Cash Flow | ₹25,353.85L | ₹24,458.38L | ₹35,892.32L | ₹13,332.12L | ₹0.00L |
| Capital Expenditure | -₹17,332.14L | -₹17,716.14L | -₹22,633.45L | -₹16,481.78L | ₹0.00L |
| Beginning Cash Position | ₹457.72L | ₹674.27L | ₹750.34L | ₹2,161.20L | ₹0.00L |
Income Statement
| Metric | 31/03/2026 | 31/03/2025 | 31/03/2024 | 31/03/2023 |
|---|---|---|---|---|
| EBIT | ₹24,461.65L | ₹24,764.40L | ₹26,904.28L | ₹25,747.53L |
| Ebit | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| EBITDA | ₹31,158.72L | ₹30,342.08L | ₹32,049.01L | ₹30,779.95L |
| Basic EPS | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Net Income | ₹19,491.74L | ₹16,815.85L | ₹17,141.82L | ₹16,630.88L |
| Diluted EPS | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Gross Profit | ₹50,645.34L | ₹47,882.54L | ₹85,086.00L | ₹48,296.91L |
| Pretax Income | ₹21,090.19L | ₹21,177.14L | ₹23,552.78L | ₹22,418.21L |
| Tax Provision | ₹1,596.41L | ₹4,367.44L | ₹6,393.71L | ₹5,782.49L |
| Total Revenue | ₹2,52,127.70L | ₹2,36,892.76L | ₹2,50,887.08L | ₹2,70,556.78L |
| Cost Of Revenue | ₹2,01,482.36L | ₹1,89,010.22L | ₹2,02,400.55L | ₹2,22,259.87L |
| Total Expenses | ₹2,26,807.93L | ₹2,12,573.90L | ₹2,23,116.73L | ₹2,43,921.83L |
| Interest Income | ₹116.78L | ₹1,239.64L | ₹249.55L | ₹69.92L |
| Interest Expense | ₹3,371.46L | ₹3,587.26L | ₹3,351.50L | ₹3,329.32L |
| Operating Income | ₹25,319.77L | ₹24,318.86L | ₹27,770.35L | ₹26,634.95L |
| Tax Rate For Calcs | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Income Tax Expense | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Normalized EBITDA | ₹31,524.84L | ₹30,714.30L | ₹32,286.10L | ₹30,933.00L |
| Normalized Income | ₹19,830.15L | ₹17,111.31L | ₹17,314.54L | ₹16,744.46L |
| Operating Expense | ₹25,325.57L | ₹23,563.68L | ₹58,585.00L | ₹21,661.96L |
| Operating Revenue | ₹2,52,127.70L | ₹2,36,892.76L | ₹2,50,887.08L | ₹2,70,556.78L |
| Net Interest Income | -₹3,512.75L | -₹2,664.11L | -₹3,539.25L | -₹3,643.88L |
| Total Unusual Items | -₹366.12L | -₹372.22L | -₹237.09L | -₹153.05L |
| Basic Average Shares | ₹912.70L | ₹912.70L | ₹919.35L | ₹926.00L |
| Diluted Average Shares | ₹912.70L | ₹912.70L | ₹919.35L | ₹926.00L |
| Total Other Finance Cost | ₹258.07L | ₹316.49L | ₹437.30L | ₹384.48L |
| Other Operating Expenses | ₹86.39L | ₹33.56L | ₹58.65L | ₹62.39L |
| Reconciled Depreciation | ₹6,697.07L | ₹5,577.68L | ₹5,144.73L | ₹5,032.41L |
| Total Operating Expenses | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Reconciled Cost Of Revenue | ₹2,01,482.36L | ₹1,89,010.22L | ₹2,02,400.55L | ₹2,22,259.87L |
| Rent Expense Supplemental | ₹29.99L | ₹23.60L | ₹6.00L | ₹6.00L |
| Tax Effect Of Unusual Items | -₹27.71L | -₹76.76L | -₹64.37L | -₹39.47L |
| Interest Income Non Operating | ₹116.78L | ₹1,239.64L | ₹249.55L | ₹69.92L |
| Selling And Marketing Expense | ₹7,843.54L | ₹6,723.93L | ₹5,768.87L | ₹6,980.67L |
| Interest Expense Non Operating | ₹3,371.46L | ₹3,587.26L | ₹3,352.00L | ₹3,329.32L |
| Net Income Common Stockholders | ₹19,491.74L | ₹16,815.85L | ₹17,141.82L | ₹16,630.88L |
| Net Income Continuous Operations | ₹19,493.78L | ₹16,809.70L | ₹17,159.07L | ₹16,635.72L |
| Diluted NIAvailto Com Stockholders | ₹19,491.74L | ₹16,815.85L | ₹17,141.82L | ₹16,630.88L |
| General And Administrative Expense | ₹2,073.19L | ₹1,769.87L | ₹1,418.35L | ₹1,378.67L |
| Selling General And Administration | ₹9,916.73L | ₹8,493.80L | ₹7,187.22L | ₹8,359.34L |
| Otherunder Preferred Stock Dividend | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Total Unusual Items Excluding Goodwill | -₹366.12L | -₹372.22L | -₹237.09L | -₹153.05L |
| Net Non Operating Interest Income Expense | -₹3,512.75L | -₹2,664.11L | -₹3,539.25L | -₹3,643.88L |
| Net Income Including Noncontrolling Interests | ₹19,493.78L | ₹16,809.70L | ₹17,159.07L | ₹16,635.72L |
| Net Income From Continuing And Discontinued Operation | ₹19,491.74L | ₹16,815.85L | ₹17,141.82L | ₹16,630.88L |
| Net Income From Continuing Operation Net Minority Interest | ₹19,491.74L | ₹16,815.85L | ₹17,141.82L | ₹16,630.88L |
Company Performance (FY23–FY26)
Directors
| Appointment | Director name | DIN | Designation | |
|---|---|---|---|---|
| 05/01/1985 | Prakash Moreshwar Patil | 00005618 | Managing Director | View other directorships |
| 02/01/1987 | Harshit Manilal Savla | 00005340 | Managing Director | View other directorships |
| 15/09/1995 | Harit Pragji Shah | 00005501 | Whole-time director | View other directorships |
| 18/10/2000 | Uday Moreshwar Patil | 01186406 | Whole-time director | View other directorships |
| 16/08/2012 | Rashesh Chandrakant Gogri | 00066291 | Managing Director | View other directorships |
| 01/04/2014 | Prakash Moreshwar Patil | *****0538K | CEO | |
| 04/04/2014 | Adhish Prakash Patil | *****5388D | CFO | |
| 23/04/2019 | Rushikesh Vivek Deole | *****6116D | Company Secretary | |
| 25/08/2020 | Narendra Jagannath Salvi | 00299202 | Director | View other directorships |
| 13/10/2021 | Ankit Vikram Paleja | 06975564 | Director | View other directorships |
| 09/05/2022 | Neha Rajen Gada | 01642373 | Director | View other directorships |
| 09/05/2022 | Bhaskar Narayan Thorat | 01293824 | Director | View other directorships |
| 29/03/2024 | Sandeep Madhusudan Joshi | 00516409 | Director | View other directorships |
| 29/03/2024 | Hasmukh Bhavanji Dedhia | 07510925 | Director | View other directorships |
| 29/03/2024 | Ajit Eledath Venugopalan | 09439069 | Director | View other directorships |
Business Network
Directors 15
- Rashesh Chandrakant GogriManaging Director
- Harshit Manilal SavlaManaging Director
- Prakash Moreshwar PatilManaging Director
- Uday Moreshwar PatilWhole-time director
- Harit Pragji ShahWhole-time director
- Ajit Eledath VenugopalanDirector
- Hasmukh Bhavanji DedhiaDirector
- Sandeep Madhusudan JoshiDirector
- Bhaskar Narayan ThoratDirector
- Neha Rajen GadaDirector
- Ankit Vikram PalejaDirector
- Narendra Jagannath SalviDirector
- Rushikesh Vivek DeoleCompany Secretary
- Adhish Prakash PatilCFO
- Prakash Moreshwar PatilCEO
Subsidiaries 1
- Pinnacle Life Science Private LimitedDirect
Latest Documents
| Date | Title | Size |
|---|---|---|
| 15/11/2024 | Form MGT-7-15112024_signed | - |
| 11/11/2024 | Form Addendum to AOC-4 CSR-11112024_signed | - |
| 08/11/2024 | Form AOC-4(XBRL)-08112024-signed | - |
| 11/01/2024 | Form Addendum to AOC-4 CSR-11012024_signed | - |
Direct/Ultimate Children
| Type | Legal Name | LEI code |
|---|---|---|
| Direct | Pinnacle Life Science Private Limited | 33580059R14T2US3K712 |
Address
Frequently Asked Questions
The current board member of Aarti Drugs Limited are:
- Harit Pragji Shah
- Uday Moreshwar Patil
- Rashesh Chandrakant Gogri
- Prakash Moreshwar Patil
- Narendra Jagannath Salvi
- Ankit Vikram Paleja
- Neha Rajen Gada
- Harshit Manilal Savla
- Bhaskar Narayan Thorat
- Sandeep Madhusudan Joshi
- Hasmukh Bhavanji Dedhia
- Ajit Eledath Venugopalan